This article is more than 5 years old. Information may no longer be current.

Bacterin announces partnership with DMP Spine Biologics

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Bacterin International Holdings Inc. has entered a partnership with DMP Spine Biologics with intent to distribute Bacterin’s biologics products in the European Union.

"We could not be more excited about this opportunity to work with such an innovative, U.S.-based tissue bank, with an incredible portfolio of products and knowledgeable management team. We have already engaged distributors through our network and will be expanding distribution into various EU countries in the very near future,” Marios Papadopoulos, chairman and chief executive officer of DMP Spine Technologies, stated in a company press release.

Daniel Goldberger, chief executive officer of Bacterin, stated that DMO Spine Biologics has extensive relationships throughout Europe and a vast knowledge of the orthopedic and spine markets in various countries.

"The European markets represent a significant opportunity for our products. This relationship will allow us to enter the European market and expand our business internationally," he stated in the release.